Ülke: İrlanda
Dil: İngilizce
Kaynak: HPRA (Health Products Regulatory Authority)
Enrofloxacin
Emdoka bvba
QJ01MA90
Enrofloxacin
50 milligram(s)/millilitre
Solution for injection
POM: Prescription Only Medicine as defined in relevant national legislation
enrofloxacin
Authorised
2013-09-27
Health Products Regulatory Authority 27 February 2019 CRN008W34 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Enrocare 50 mg/ml Solution for Injection for Cattle, Pigs, Dogs and Cats 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml of the solution for injection contains: ACTIVE SUBSTANCE:MG Enrofloxacin 50 EXCIPIENTS: Butyl alcohol as antimicrobial preservative 30 For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection. Clear, light yellow, sterile, aqueous solution 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle (calves) Pigs weighing more than 25kg Dogs and cats 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Calves Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of _Pasteurella multocida, Mannheimia_ _haemolytica _and _Mycoplasma _spp. Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of _Escherichia coli_. Treatment of septicaemia caused by enrofloxacin susceptible strains of _Escherichia coli_. Treatment of acute mycoplasma-associated arthritis due to enrofloxacin susceptible strains of _Mycoplasma bovis_. Pigs Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of _Pasteurella multocida, Mycoplasma _ spp. and _Actinobacillus pleuropneumoniae_. Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of _Escherichia coli_. Treatment of septicaemia caused by enrofloxacin susceptible strains of _Escherichia coli. _ Dogs Treatment of infections of the alimentary, respiratory and urogenital tracts (including prostatitis, adjunctive antibiotic therapy for pyometra), skin and wound infections, otitis (externa/media) caused by enrofloxacin susceptible strains of _Staphylococcus _ spp_., Escherichia coli, Pasteurella _spp_., Klebsiella _spp_., Bordetella _spp_., Pseudomonas _spp_. _and _Proteus _spp_. _ Cats Treatment of infections of the alimentary, respiratory and uroge Belgenin tamamını okuyun